Bimuno Prebiotic Powder

Bimuno Powder

Information for Healthcare Professionals: Bimuno is a soluble powder proven to encourage the growth of good bacteria in the gut & optimise nutritional balance.


What is Bimuno® Powder?

Bimuno® Prebiotic Powder was the first Bimuno® product to become available in the UK. It is formulated to provide greater functionality than probiotic supplements and 1st generation prebiotics.

Promoted as ‘Prebiotic Power for Your Gut’, the product is designed to provide a:

  • Powerful prebiotic effect, increasing and strengthening beneficial bacteria
  • Powerful bifidogenic effect, increasing and strengthening immunity boosting bifidobacteria
  • Unique anti-pathogenic action, preventing the attachment and colonization of G.I. pathogens.

Bimuno® Powder provides scientifically proven gut and immune health benefits.

Why recommend Bimuno® prebiotic powder?

The health of the gut is fundamental to human nutrition and the avoidance of gastrointestinal disease. Beneficial gut bacteria, especially bifidobacteria, and the immune system are responsible for preventing the penetration of immunogenic components and protecting against pathogenic bacteria.

A positive bacterial balance is required to help maintain immune health and general wellbeing.

Probiotic supplements and foods may have a restricted role in the management of gut health due to the problems associated with the survivability of the live bacteria and delivery to the large intestine1. Bimuno® reaches the lower gut intact, allowing for maximum impact.

1st generation prebiotics (food source for the gut’s beneficial bacteria) lack the added specificity and functionality required to further enhance gut and immune health.

The scientific evidence behind Bimuno®

Scientific research and clinical studies have produced evidence of Bimuno® contributing to the following:

  • Prevention of pathogenic G.I. bacteria colonisation2,3
  • Energising (increases and strengthens) the body’s immunity boosting bacteria (bifidobacteria)4
  • Immune health maintenance in the elderly5
  • Enhancement of bifidobacterial population, normally depleted in IBS sufferers6
  • Gut health maintenance whilst travelling abroad7

Who can benefit from Bimuno® Prebiotic Powder?

Patients suffering from G.I. related problems and those who are proactive about their gut health and general wellbeing can benefit from taking Bimuno® Prebiotic Powder. [link to product page]

This particular Bimuno® product is more suitable for those who prefer powder, as opposed to pastilles. It is also suitable for children aged 3 to 11 years.

Bimuno® Prebiotic Powder is ideal for individuals wishing to actively support their gut health and general well-being on an on-going basis.

Recommending Bimuno® Prebiotic Powder

Bimuno® Prebiotic Powder [link to product page] is classed as a food supplement and does not have any of the warnings and contra-indications associated with medicinal products. It is not a medicinal product and is not intended to treat or prevent medical conditions or their symptoms.

Although no adverse effects have been reported, it should be noted that Bimuno® Prebiotic Powder contains small amounts of lactose (from milk).

One pack contains 30 sachets, each containing 5.5g of powder. The active ingredient is galacto-oligosaccharides equivalent to a daily serving (dose) of 2.75g.

Bimuno® Prebiotic Powder is free from artificial colours, flavours and preservatives and is gluten free. The lactose content is 1.5g* per daily serving. Per daily dose it contains 15 kcal, 1.9g of sugar and 0.03g of fat.

It is suitable for adults and children aged 3 years and over.

Bimuno® Prebiotic Powder [link to product page] can be added to everyday food and drink e.g. cereal, yoghurt, coffee or tea.

Recommended serving:

  • Children 12 years and over and adults: 1 sachet (5.5g) daily.
  • Children 3 to 11 years: ½ a sachet daily (2.75g).
  • Since the benefits build over time, a daily intake is recommended.

* Lactose doses of less than 10g per day are likely to be tolerated by most of the population of lactose deficient adults. EFSA Journal (2007) 565,1-6.


1. Gibson GR et al.
2. Tzortzis et al. J Nutr 2005;135:1726-1731.
3. Searle LEJ et al. Journal of Medical Microbiology 2009;58:37-48.
4. Depeint F et al. Am J Clin Nutr 2008;87:785-91.
5. Vulevic J et al. Am J Clin Nutr 2008;88:1438-46.
6. Silk DBA et al. Aliment Pharmacol Ther 2009;29:508-518.
7. Drakoularakou A et al. European Journal of Clinical Nutrition 2010;64:146-152.


Back to Healthcare Professionals


This section is an information and educational resource for healthcare professionals, scientists, researchers and journalists. It is not intended for consumers. If you wish to purchase Bimuno please click here

Back to the top